A Study of VRC07-523LS, PGT121.414.LS, and PGDM1400LS Broadly Neutralizing Monoclonal Antibodies Given Intravenously in Adult Participants Without HIV | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of VRC07-523LS, PGT121.414.LS, and PGDM1400LS Broadly Neutralizing Monoclonal Antibodies Given Intravenously in Adult Participants Without HIV	HIV	Active, not recruiting	Phase 2	2026-08-21		NCT06812494

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Dale and Betty Bumpers Vaccine Research Center (VRC)	1
Department of Health and Human Services	32
National Institute of Allergy and Infectious Diseases (NIAID)	402
National Institutes of Health (NIH)	667

17 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Alabama CRA (Site #31788)	Birmingham	United States	1
BIDMC VCRS (Site ID# 32077)	Boston	United States	1
Bridge HIV, San Francisco Department of Public Health	San Francisco	United States	4
Brigham and Women's Hospital Vaccine CRS (BWH VCRS)	Boston	United States	2
Chapel Hill CRS (Site #3201)	Chapel Hill	United States	1
CITBM CRS (Site ID 31970)	Callao	Peru	1
Columbia P&S CRS	New York	United States	4
Fenway Health	Boston	United States	1
Instituto de Pesquisa Clinica Evandro Chagas (IPEC) CRS	Rio de Janeiro	Brazil	1
Penn Prevention CRS	Philadelphia	United States	1
San Miguel CRS (Site #11302)	Lima	Peru	1
Seattle Vaccine and Prevention CRS (Site ID# 30331)	Seattle	United States	1
The Hope Clinic of the Emory Vaccine Research Center; Emory University	Decatur	United States	3
University of Pittsburgh CRS (Site 1001)	Pittsburgh	United States	1
University of Rochester Vaccines to Prevent HIV Infection CRS (Site ID 31467)	Rochester	United States	2
Vanderbilt Vaccine (VV) CRS	Nashville	United States	2
Via Libre (Site ID 31909)	Lima	Peru	1